Pfizer Inc

Holdings as of Sep 30, 2026 · filed Nov 12, 2026

$164248920
Portfolio value
17
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Allogene Therapeutics Inc $36352866 22.13% — Held
2 Arvinas Inc $26244816 15.98% — Held
3 Celcuity Inc $23510247 14.31% — Held
4 Agomab Therapeutics Nv $22609249 13.77% +2076213 +2768.28%
5 Pyxis Oncology Inc $20113722 12.25% — Held
6 Wave Life Sciences Inc $7087500 4.32% — NEW BUY
7 Biohaven Ltd $6568329 4.00% — Held
8 Caribou Biosciences Inc $5816134 3.54% — Held
9 Oric Pharmaceuticals Inc $4907417 2.99% — Held
10 Cardiff Oncology Inc $2990353 1.82% — Held
11 Spero Therapeutics Inc $2905688 1.77% — Held
12 Zentalis Pharmaceuticals Inc $2575352 1.57% — Held
13 Zura Bio Ltd $2176918 1.33% — Held
14 Nextcure Inc $225334 0.14% +10 +0.02%
15 Bolt Biotherapeutics Inc $112072 0.07% — Held
16 Ginkgo Bioworks Holdings Inc $31213 0.02% — Held
17 Senseonics Hldgs Inc $21710 0.01% — NEW BUY

Closed last quarter

Wave Life Sciences Ltd Senseonics Hldgs Inc

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.